SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors react to a strong earnings report and the companys decision to maintain capital expenditure levels, which has effectively eased market anxiety regarding AI infrastructure spending. The community is actively debating the company's ability to drive long-term cloud and AI growth while highlighting its status as a stabilizing force amid broader market volatility.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are facing downward pressure as investors react to a significant earnings miss and raised capital expenditure guidance for AI infrastructure, which has severely compressed free cash flow. While some in the community argue this represents a durable, long-term buying opportunity in an advertising cash cow, others are actively debating whether these heavy investments can yield sufficient returns or if they will continue to weigh on shareholder value.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad regulatory approval of Anktiva, which marks a significant milestone in the company's global expansion and validates its therapeutic potential. While the community is actively debating the significance of international market entry versus the need for more substantial domestic clinical updates, many investors remain focused on upcoming quarterly earnings as a key indicator of commercial growth and a potential catalyst for price action.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as a sharp spike in Treasury yields and ongoing geopolitical instability in the Middle East fuel investor concerns over long-term inflation and the viability of long-duration bonds. The community is actively debating whether this represents a critical flight-to-safety opportunity or a signal of deeper systemic economic weakness ahead of upcoming economic data.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny as investors weigh the stock's recent price stagnation against the heavy capital expenditure requirements for AI infrastructure and data center expansion. The community remains divided, with many traders closely monitoring AWS performance and management's guidance on long-term AI profitability ahead of upcoming earnings.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing significant market attention following a better-than-expected Q2 earnings report, with community discussion centered on successful growth initiatives like menu innovation and AI-driven efficiency. While some investors are highlighting the raised full-year outlook and strong demand as a bullish signal, others remain focused on broader sector concerns regarding consumer spending resilience and supply chain management.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor interest driven by a series of record-breaking ABS issuances and strong analyst support that suggests the company is significantly undervalued relative to its fintech peers. The community remains focused on whether management's bullish execution and insider share purchases by the CEO will be enough to overcome broader macro volatility and lingering concerns about credit performance.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is currently grappling with heightened volatility as market participants weigh aggressive institutional put buying against resilience in small-cap sectors. Traders are heavily focused on the interplay between climbing bond yields, geopolitical instability, and anticipation of the upcoming Fed rate decision, which is forcing a shift in sentiment regarding whether small caps can maintain their current support levels.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining significant community attention as shareholders speculate on a potential buyout following recent analyst price target hikes and ongoing momentum from Briumvi's commercial success. Investors are closely monitoring strong revenue growth and upcoming clinical trial developments while actively debating the stock's valuation relative to its expansion into new autoimmune indications.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc. is experiencing high volatility as shareholders react to the FDA accepting a resubmission for its melanoma treatment, with many community members debating whether this third attempt will yield a favorable outcome or another Complete Response Letter. Investors are closely monitoring upcoming advisory committee meetings and the potential for significant dilution, while the community remains polarized between those anticipating an approval-driven squeeze and others warning of a permanent decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CTS (CTS) Q2 Earnings and Revenues Beat Estimates

CTS (CTS) delivered earnings and revenue surprises of +21.31% and +0.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

TTDKY or CTS: Which Is the Better Value Stock Right Now?

TTDKY vs. CTS: Which Stock Is the Better Value Option?

Vicor Surges 621% in the Past Year: Should You Buy the Stock?

VICR's 621% surge reflects rising AI power demand, proprietary technologies, IP licensing growth and manufacturing leverage supporting long-term gains.

Littelfuse Rides on Holistic Growth Focus: Should You Buy the Stock?

A balanced growth strategy, innovation push and selective buyouts support the long-term growth prospects of LFUS across electrification and power infrastructure.

Vishay Precision Surges 373% in the Past Year: Time to Buy the Stock?

VPG's 373% surge, precision sensing portfolio, and exposure to automation, EVs, robotics and defense signal potential for long-term growth.

SNX Q2 Earnings Beat Estimates on Broad-Based Growth & Hyve Strength

SNX delivers a strong fiscal Q2 earnings beat as broad-based growth and surging Hyve demand drive record billings and support upbeat Q3 guidance.

CTS Promotes COO Pratik Trivedi To President And CEO

(RTTNews) - CTS Corp. (CTS) announced Thursday that its Board of Directors has promoted Pratik Trivedi, CTS' current COO, to Chief Executive Officer and President effective July 6, 2026...

CTS (CTS) Is a Great Choice for 'Trend' Investors, Here's Why  

CTS (CTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

What Makes CTS (CTS) a Strong Momentum Stock: Buy Now?

Does CTS (CTS) have what it takes to be a top stock pick for momentum investors? Let's find out.

CTS (CTS) is on the Move, Here's Why the Trend Could be Sustainable 

If you are looking for stocks that are well positioned to maintain their recent uptrend, CTS (CTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

$CTS Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.67 up 8.06% YoY
• Reported revenue of $144.78M up 7.00% YoY
• Assuming the continuation of current market conditions, CTS is increasing its previous guidance of 2026 sales to a range of $565-$585 million and adjusted diluted EPS to $2.55-$2.70.

Stocktwits

CTS Corp.

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.67 up 8.06% YoY
• Reported revenue of $144.78M up 7.00% YoY
• Assuming the continuation of current market conditions, CTS is increasing its previous guidance of 2026 sales to a range of $565-$585 million and adjusted diluted EPS to $2.55-$2.70.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

CTS Corp. engages in the design and manufacture of sensors, connectivity components, and actuators. Its products include controls, pedals, piezo sensing products, sensors, switches, transducers, electromagnetic and radio frequency interference filters, capacitors, frequency control, resistors, piezo microactuators, and rotary microactuators. The company was founded by A. J. Briggs, George A. Briggs, and S. A. Buffington in 1896 and is headquartered in Lisle, IL.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CTSCTS Corp.

Fundamentals

Latest CTS News